Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

by · The Markets Daily

StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP – Free Report) in a report released on Wednesday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Several other equities research analysts have also weighed in on the company. Piper Sandler dropped their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday, March 28th. Jefferies Financial Group reiterated a “hold” rating and set a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. Finally, HC Wainwright reiterated a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a report on Friday, March 28th.

Check Out Our Latest Stock Report on EDAP

Edap Tms Stock Performance

Shares of EDAP stock opened at $2.22 on Wednesday. The stock has a 50 day moving average price of $1.96 and a two-hundred day moving average price of $2.27. Edap Tms has a fifty-two week low of $1.26 and a fifty-two week high of $7.14. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. The company has a market capitalization of $82.37 million, a P/E ratio of -3.42 and a beta of 0.13.

Edap Tms (NASDAQ:EDAP – Get Free Report) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. Analysts expect that Edap Tms will post -0.6 earnings per share for the current year.

Hedge Funds Weigh In On Edap Tms

Institutional investors and hedge funds have recently made changes to their positions in the business. Cetera Investment Advisers raised its holdings in Edap Tms by 33.9% in the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock worth $147,000 after purchasing an additional 19,000 shares during the period. Millennium Management LLC boosted its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 25,650 shares during the last quarter. Jane Street Group LLC grew its holdings in Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC grew its holdings in shares of Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

Featured Articles